title: Intravenous ascorbic acid: protocol for its application and use.
abstract: High dose intravenous(i.v.) ascorbic acid (AA) has been used as therapy for infectious disease from bacterial and viral origin and adjuvant therapy for cancer. In this publication we describe a clinical protocol that has been developed over the past twenty years utilizing high dose i.v. AA as therapy for cancer. This includes principles of treatment, rationale, baseline workup, infusion protocol, precautions and side effects.
authors: Center for the Improvement of Human Functioning, Biocommunications Research Institute, Wichita, KS, USA.
authors: Hugh D
authors: HD
authors: Riordan
authors: Ronald B
authors: RB
authors: Hunninghake
authors: Neil H
authors: NH
authors: Riordan
authors: James J
authors: JJ
authors: Jackson
authors: Xiaolong
authors: X
authors: Meng
authors: Paul
authors: P
authors: Taylor
authors: Joseph J
authors: JJ
authors: Casciari
authors: Michael J
authors: MJ
authors: González
authors: Jorge R
authors: JR
authors: Miranda-Massari
authors: Edna M
authors: EM
authors: Mora
authors: Norberto
authors: N
authors: Rosario
authors: Alfredo
authors: A
authors: Rivera
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002985:Clinical Protocols; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000188:drug therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects; D014777:Virus Diseases / Q000188:drug therapy
chemical_list: D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D001205:Ascorbic Acid